Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

E C de Heer; C E Zois; E Bridges; B van der Vegt; H Sheldon; W A Veldman; M C Zwager; T van der Sluis; S Haider; T Morita; O Baba; C P Schröder; S de Jong; A L Harris; M Jalving

doi:10.1186/s13046-023-02800-3

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

E C de Heer, C E Zois^*, E Bridges, B van der Vegt, H Sheldon, W A Veldman, M C Zwager, T van der Sluis, S Haider, T Morita, O Baba, C P Schröder, S de Jong, A L Harris, M Jalving^*

^*Corresponding author voor dit werk

Onderzoeksoutput

41 Downloads (Pure)

Originele taal-2	English
Artikelnummer	220
Aantal pagina's	1
Tijdschrift	Journal of experimental & clinical cancer research
Volume	42
DOI's	https://doi.org/10.1186/s13046-023-02800-3
Status	Published - 28-aug.-2023

Toegang tot document

10.1186/s13046-023-02800-3Licentie: CC BY

CorrectionFinal publisher's version, 784 KBLicentie: CC BY

Handle.net

Permanente koppeling

1 Article

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L. & Jalving, M., 6-jun.-2023, In: Journal of experimental & clinical cancer research. 42, 14 blz., 143.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
10 Citaten (Scopus)

94 Downloads (Pure)

Citeer dit

de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L., & Jalving, M. (2023). Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. Journal of experimental & clinical cancer research, 42, Artikel 220. https://doi.org/10.1186/s13046-023-02800-3

@article{c02d668ec1524512a335cf8dc81ed15a,

title = "Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer",

author = "{de Heer}, {E C} and Zois, {C E} and E Bridges and {van der Vegt}, B and H Sheldon and Veldman, {W A} and Zwager, {M C} and {van der Sluis}, T and S Haider and T Morita and O Baba and Schr{\"o}der, {C P} and {de Jong}, S and Harris, {A L} and M Jalving",

year = "2023",

month = aug,

day = "28",

doi = "10.1186/s13046-023-02800-3",

language = "English",

volume = "42",

journal = "Journal of experimental & clinical cancer research",

issn = "0392-9078",

publisher = "BMC",

}

de Heer, EC, Zois, CE, Bridges, E, van der Vegt, B, Sheldon, H, Veldman, WA, Zwager, MC , van der Sluis, T, Haider, S, Morita, T, Baba, O, Schröder, CP , de Jong, S, Harris, AL & Jalving, M 2023, 'Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer', Journal of experimental & clinical cancer research, vol. 42, 220. https://doi.org/10.1186/s13046-023-02800-3

TY - JOUR

T1 - Correction

T2 - Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

AU - de Heer, E C

AU - Zois, C E

AU - Bridges, E

AU - van der Vegt, B

AU - Sheldon, H

AU - Veldman, W A

AU - Zwager, M C

AU - van der Sluis, T

AU - Haider, S

AU - Morita, T

AU - Baba, O

AU - Schröder, C P

AU - de Jong, S

AU - Harris, A L

AU - Jalving, M

PY - 2023/8/28

Y1 - 2023/8/28

U2 - 10.1186/s13046-023-02800-3

DO - 10.1186/s13046-023-02800-3

M3 - Erratum

C2 - 37635223

SN - 0392-9078

VL - 42

JO - Journal of experimental & clinical cancer research

JF - Journal of experimental & clinical cancer research

M1 - 220

ER -

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Toegang tot document

Handle.net

Onderzoekersoutput

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Citeer dit